Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine Combined Dexmedetomidine for Obturator Nerve Block

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects scheduled to undergo elective operation of TURBT on lateral wall for whom ONB was needed diagnosed through cystoscopy or CT examination preoperatively.~2. Subject's American Society of Anesthesiologists physical status is I-II.~3. The subject's parent/legally authorized guardian has given written informed consent to participate.~Exclusion Criteria:~1. Subject has a diagnosis of abnormal coagulation function.~2. Subject has a diagnosis of Diabetes mellitus.~3. Subject has a preexisting neurologic deficits of the lower extremities.~4. Subject has a history of alcohol or drug abuse.~5. Subject is pregnant or breast-feeding.~6. Subject is obese (body mass index \>30kg/m2).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine (Type: ACTIVE_COMPARATOR): Dexmedetomidine is administrated as an adjuvant of lidocaine at a dose of 1.0 μg/ kg.
- Normal Saline (Type: PLACEBO_COMPARATOR): Normal Saline is administrated as an adjuvant of lidocaine.

Based on this trial design, predict the completion outcome and termination type (if applicable).